IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aclaris Therapeutics, Inc.

Q3 2019 vs Q4 2019

Comparing institutional holders between quarters

Quarters

Q4 2019Q3 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Vivo Capital, LLC
INCREASED
Shares101,392,395 from 82,834,668
Change+18,557,727 (+22%)
Value$1,000.0K (+$399.8K)
Filed 2020-02-25
Status
Vivo Capital, LLC
INCREASED101,392,39582,834,668+18,557,727+22%$600.2K$1,000.0K+$399.8K2020-02-25
Showing 1 of 1 institutions